Details for: ATP2B2
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 54.72rCSI 68.08%PRS 98.86
-
CSI 50.54rCSI 74.3%PRS 99.21
-
CSI 45.94rCSI 54.87%PRS 98.93
-
CSI 43.47rCSI 71.19%PRS 99.11
-
CSI 39.89rCSI 51.42%PRS 99.21
-
CSI 33.65rCSI 54.12%PRS 98.81
-
CSI 31.1rCSI 52.2%PRS 98.97
-
CSI 31.06rCSI 54.86%PRS 98.94
-
CSI 30.11rCSI 60.46%PRS 99.41
-
CSI 27.13rCSI 58.86%PRS 98.57
-
CSI 25.36rCSI 61.62%PRS 98.49
-
CSI 24.04rCSI 57.5%PRS 98.72
-
CSI 21.87rCSI 39.29%PRS 99.37
-
CSI 21.78rCSI 34.75%PRS 99.22
-
CSI 21.45rCSI 67.07%PRS 99.08
-
CSI 21.33rCSI 66.67%PRS 98.91
-
CSI 21.22rCSI 49%PRS 99.1
-
CSI 20.56rCSI 46.91%PRS 99.23
-
CSI 19.98rCSI 53.21%PRS 98.31
-
CSI 19.65rCSI 39.88%PRS 97.51
-
CSI 19.18rCSI 69.02%PRS 98.72
-
CSI 19.15rCSI 35.86%PRS 98.99
-
CSI 18.92rCSI 38.88%PRS 97.73
-
CSI 18.87rCSI 44.28%PRS 99.49
-
CSI 18.45rCSI 41.36%PRS 99.03
-
CSI 18.01rCSI 73.39%PRS 99
-
CSI 17.73rCSI 67%PRS 98.64
-
CSI 17.39rCSI 57.15%PRS 98.46
-
CSI 17.33rCSI 25.75%PRS 99.42
-
CSI 16.14rCSI 20.71%PRS 99.57
-
CSI 15.77rCSI 24.04%PRS 99.56
-
CSI 14.99rCSI 56.57%PRS 98.37
-
CSI 14.74rCSI 56.11%PRS 98.87
-
CSI 14.04rCSI 31.02%PRS 98.97
-
CSI 13.89rCSI 24.86%PRS 99.32
-
CSI 12.93rCSI 22.36%PRS 99.31
-
CSI 12.03rCSI 46.77%PRS 99.33
-
CSI 11.54rCSI 67.92%PRS 98.73
-
CSI 11.38rCSI 15.58%PRS 99.18
-
CSI 10.9rCSI 31.6%PRS 99.15
-
CSI 10.85rCSI 36.35%PRS 97.54
-
CSI 10.47rCSI 44.5%PRS 99.62
-
CSI 9.56rCSI 24.9%PRS 98.97
-
CSI 9.42rCSI 17.12%PRS 99.33
-
CSI 9.26rCSI 41.38%PRS 97.95
-
CSI 8.71rCSI 49.25%PRS 98.71
-
CSI 8.49rCSI 14.89%PRS 99.49
-
CSI 8.36rCSI 11.43%PRS 99.44
-
CSI 7.66rCSI 26.22%PRS 98.55
-
CSI 7.39rCSI 54.34%PRS 99.11
-
CSI 6.9rCSI 30.38%PRS 97.17
-
CSI 6.82rCSI 58.74%PRS 99.06
-
CSI 6.42rCSI 16.74%PRS 99.23
-
CSI 6.2rCSI 14.78%PRS 99.72
-
CSI 5.51rCSI 27.38%PRS 99.27
-
CSI 5.45rCSI 21.57%PRS 99.04
-
CSI 5.27rCSI 35.9%PRS 98.55
-
CSI 4.93rCSI 43.36%PRS 98.49
-
CSI 4.81rCSI 68.25%PRS 98.99
-
CSI 4.5rCSI 8.94%PRS 99.27
-
CSI 3.57rCSI 72.69%PRS 98.92
-
CSI 3.45rCSI 70.26%PRS 98.99
-
CSI 3.25rCSI 19.17%PRS 98.51
-
CSI 3.21rCSI 76.75%PRS 98.09
-
CSI 3.17rCSI 76.49%PRS 98.11
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 1546578330
Symbol: AT2B2_HUMAN
Name: Plasma membrane calcium-transporting ATPase 2
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 1427863
Title: Determination of the nucleotide sequence and chromosomal localization of the ATP2B2 gene encoding human Ca(2+)-pumping ATPase isoform PMCA2.
PubMed ID: 1427863
PubMed ID: 8428366
Title: von Hippel-Lindau syndrome: cloning and identification of the plasma membrane Ca(++)-transporting ATPase isoform 2 gene that resides in the von Hippel-Lindau gene region.
PubMed ID: 8428366
PubMed ID: 1313367
Title: Microdiversity of human-plasma-membrane calcium-pump isoform 2 generated by alternative RNA splicing in the N-terminal coding region.
PubMed ID: 1313367
PubMed ID: 16641997
Title: The DNA sequence, annotation and analysis of human chromosome 3.
PubMed ID: 16641997
DOI: 10.1038/nature04728
PubMed ID: 8245032
Title: Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes.
PubMed ID: 8245032
PubMed ID: 7989379
PubMed ID: 12763866
Title: Characterization of PISP, a novel single-PDZ protein that binds to all plasma membrane Ca2+-ATPase b-splice variants.
PubMed ID: 12763866
PubMed ID: 12624087
Title: Alternative splicing of the first intracellular loop of plasma membrane Ca2+-ATPase isoform 2 alters its membrane targeting.
PubMed ID: 12624087
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 24275569
Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
PubMed ID: 24275569
PubMed ID: 25690014
Title: Plasma membrane Ca2+-ATPases can shape the pattern of Ca2+ transients induced by store-operated C2+ entry.
PubMed ID: 25690014
PubMed ID: 15829536
Title: Modification of human hearing loss by plasma-membrane calcium pump PMCA2.
PubMed ID: 15829536
DOI: 10.1056/nejmoa043899
PubMed ID: 17234811
Title: A functional study of plasma-membrane calcium-pump isoform 2 mutants causing digenic deafness.
PubMed ID: 17234811
PubMed ID: 30535804
Title: De novo and inherited loss-of-function variants of ATP2B2 are associated with rapidly progressive hearing impairment.
PubMed ID: 30535804
Sequence Information:
- Length: 1243
- Mass: 136876
- Checksum: 7F10221B7B9AC3A2
- Sequence:
MGDMTNSDFY SKNQRNESSH GGEFGCTMEE LRSLMELRGT EAVVKIKETY GDTEAICRRL KTSPVEGLPG TAPDLEKRKQ IFGQNFIPPK KPKTFLQLVW EALQDVTLII LEIAAIISLG LSFYHPPGEG NEGCATAQGG AEDEGEAEAG WIEGAAILLS VICVVLVTAF NDWSKEKQFR GLQSRIEQEQ KFTVVRAGQV VQIPVAEIVV GDIAQVKYGD LLPADGLFIQ GNDLKIDESS LTGESDQVRK SVDKDPMLLS GTHVMEGSGR MLVTAVGVNS QTGIIFTLLG AGGEEEEKKD KKGVKKGDGL QLPAADGAAA SNAADSANAS LVNGKMQDGN VDASQSKAKQ QDGAAAMEMQ PLKSAEGGDA DDRKKASMHK KEKSVLQGKL TKLAVQIGKA GLVMSAITVI ILVLYFTVDT FVVNKKPWLP ECTPVYVQYF VKFFIIGVTV LVVAVPEGLP LAVTISLAYS VKKMMKDNNL VRHLDACETM GNATAICSDK TGTLTTNRMT VVQAYVGDVH YKEIPDPSSI NTKTMELLIN AIAINSAYTT KILPPEKEGA LPRQVGNKTE CGLLGFVLDL KQDYEPVRSQ MPEEKLYKVY TFNSVRKSMS TVIKLPDESF RMYSKGASEI VLKKCCKILN GAGEPRVFRP RDRDEMVKKV IEPMACDGLR TICVAYRDFP SSPEPDWDNE NDILNELTCI CVVGIEDPVR PEVPEAIRKC QRAGITVRMV TGDNINTARA IAIKCGIIHP GEDFLCLEGK EFNRRIRNEK GEIEQERIDK IWPKLRVLAR SSPTDKHTLV KGIIDSTHTE QRQVVAVTGD GTNDGPALKK ADVGFAMGIA GTDVAKEASD IILTDDNFSS IVKAVMWGRN VYDSISKFLQ FQLTVNVVAV IVAFTGACIT QDSPLKAVQM LWVNLIMDTF ASLALATEPP TETLLLRKPY GRNKPLISRT MMKNILGHAV YQLALIFTLL FVGEKMFQID SGRNAPLHSP PSEHYTIIFN TFVMMQLFNE INARKIHGER NVFDGIFRNP IFCTIVLGTF AIQIVIVQFG GKPFSCSPLQ LDQWMWCIFI GLGELVWGQV IATIPTSRLK FLKEAGRLTQ KEEIPEEELN EDVEEIDHAE RELRRGQILW FRGLNRIQTQ IRVVKAFRSS LYEGLEKPES RTSIHNFMAH PEFRIEDSQP HIPLIDDTDL EEDAALKQNS SPPSSLNKNN SAIDSGINLT TDTSKSATSS SPGSPIHSLE TSL
Genular Protein ID: 3104396399
Symbol: Q4LE63_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Sequence Information:
- Length: 1210
- Mass: 133770
- Checksum: 57832447CF2C571B
- Sequence:
PLGPARARTA ANMGDMTNSD FYSKNQRNES SHGGEFGCTM EELRSLMELR GTEAVVKIKE TYGDTEAICR RLKTSPVEGL PGTAPDLEKR KQIFGQNFIP PKKPKTFLQL VWEALQDVTL IILEIAAIIS LGLSFYHPPG EGNEGCATAQ GGAEDEGEAE AGWIEGAAIL LSVICVVLVT AFNDWSKEKQ FRGLQSRIEQ EQKFTVVRAG QVVQIPVAEI VVGDIAQVKY GDLLPADGLF IQGNDLKIDE SSLTGESDQV RKSVDKDPML LSGTHVMEGS GRMLVTAVGV NSQTGIIFTL LGAGGEEEEK KDKKAKQQDG AAAMEMQPLK SAEGGDADDR KKASMHKKEK SVLQGKLTKL AVQIGKAGLV MSAITVIILV LYFTVDTFVV NKKPWLPECT PVYVQYFVKF FIIGVTVLVV AVPEGLPLAV TISLAYSVKK MMKDNNLVRH LDACETMGNA TAICSDKTGT LTTNRMTVVQ AYVGDVHYKE IPDPSSINTK TMELLINAIA INSAYTTKIL PPEKEGALPR QVGNKTECGL LGFVLDLKQD YEPVRSQMPE EKLYKVYTFN SVRKSMSTVI KLPDESFRMY SKGASEIVLK KCCKILNGAG EPRVFRPRDR DEMVKKVIEP MACDGLRTIC VAYRDFPSSP EPDWDNENDI LNELTCICVV GIEDPVRPEV PEAIRKCQRA GITVRMVTGD NINTARAIAI KCGIIHPGED FLCLEGKEFN RRIRNEKGEI EQERIDKIWP KLRVLARSSP TDKHTLVKGI IDSTHTEQRQ VVAVTGDGTN DGPALKKADV GFAMGIAGTD VAKEASDIIL TDDNFSSIVK AVMWGRNVYD SISKFLQFQL TVNVVAVIVA FTGACITQDS PLKAVQMLWV NLIMDTFASL ALATEPPTET LLLRKPYGRN KPLISRTMMK NILGHAVYQL ALIFTLLFVG EKMFQIDSGR NAPLHSPPSE HYTIIFNTFV MMQLFNEINA RKIHGERNVF DGIFRNPIFC TIVLGTFAIQ IVIVQFGGKP FSCSPLQLDQ WMWCIFIGLG ELVWGQVIAT IPTSRLKFLK EAGRLTQKEE IPEEELNEDV EEIDHAEREL RRGQILWFRG LNRIQTQIRV VKAFRSSLYE GLEKPESRTS IHNFMAHPEF RIEDSQPHIP LIDDTDLEED AALKQNSSPP SSLNKNNSAI DSGINLTTDT SKSATSSSPG SPIHSLETSL